Org.nr 981 363 019 AS · OSLO · 21.200 Produksjon av farmasøytiske preparater Kjelsåsveien 161, 0884 OSLO Latest filing: Årsregnskap 2025 · approved 29.06.2026 · journal 2026 620661 Analysis generated: 20 Aug 2026 · Auto-onboard

ABBOTT DIAGNOSTICS TECHNOLOGIES AS

ABBOTT DIAGNOSTICS TECHNOLOGIES AS · 26 published annual accounts (2000–2025). Latest year revenue 1734.1m NOK, net result 118.9m NOK, equity 644.2m NOK, cash 12.1m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2000–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 1734.1m

Operating income / revenue in 2025.

Did they make money?
118.9m

Net result for 2025.

What’s left in the company
Equity 644.2m

Book equity at year-end.

Cash
12.1m

Bank deposits and cash (when disclosed).

Key figures

Revenue / sales
1 734 077 889
NOK · [R2025]
Net result
118 851 830
NOK · [R2025]
Equity
644 157 403
NOK · [R2025]
Cash
12 058 256
NOK · [R2025]
Total assets
1 281 317 591
NOK · [R2025]
Paid-in equity
439 889 993
NOK · [R2025]

26-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.